Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Neos Therapeutics, Inc. (NEOS) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Neos Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1467652.
Total stock buying since 2015: $7,201,073.
Total stock sales since 2015: $3,297,015.
Total stock option exercises since 2015: $40,291.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2018 | 72,978 | $162,060 | 0 | $0 | 0 | $0 |
2016 | 35,652 | $289,013 | 78,335 | $797,025 | 0 | $0 |
2015 | 450,000 | $6,750,000 | 166,666 | $2,499,990 | 30,950 | $40,291 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2018-12 | 29,500 | $62,061 | 0 | $0 | 0 | $0 |
2018-11 | 43,478 | $99,999 | 0 | $0 | 0 | $0 |
2016-08 | 5,210 | $35,093 | 0 | $0 | 0 | $0 |
2016-06 | 10,000 | $99,000 | 0 | $0 | 0 | $0 |
2016-05 | 20,442 | $154,920 | 0 | $0 | 0 | $0 |
2016-04 | 0 | $0 | 78,335 | $797,025 | 0 | $0 |
2015-09 | 0 | $0 | 0 | $0 | 410 | $131 |
2015-07 | 450,000 | $6,750,000 | 166,666 | $2,499,990 | 30,540 | $40,160 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2018-12-12 | Eisenstadt Richard I (Chief Financial Officer) | Buy | 5,000 | 2.16 | 10,820 |
2018-12-06 | Mclaughlin Gerald W. (Chief Executive Officer) | Buy | 17,097 | 2.11 | 36,125 |
2018-12-04 | Mclaughlin Gerald W. (Chief Executive Officer) | Buy | 7,403 | 2.04 | 15,116 |
2018-11-08 | Heller Alan L (Director) | Buy | 43,478 | 2.30 | 99,999 |
2016-08-31 | Fong Bryant | Buy | 1,500 | 6.54 | 9,810 |
2016-08-25 | Eisenstadt Richard I (Chief Financial Officer) | Buy | 3,710 | 6.82 | 25,283 |
2016-06-13 | Martens Juergen (Chief Tech/Operations Officer) | Buy | 10,000 | 9.90 | 99,000 |
2016-05-19 | Mcdonnell Thomas P (Chief Commercial Officer) | Buy | 3,000 | 7.56 | 22,671 |
2016-05-19 | Heller Alan L | Buy | 10,000 | 7.61 | 76,100 |
2016-05-18 | Robitaille Gregory J | Buy | 7,442 | 7.54 | 56,149 |
2016-04-20 | Sohail Faysal A. (10% Owner) | Sale | 8,540 | 9.88 | 84,409 |
2016-04-19 | Sohail Faysal A. (10% Owner) | Sale | 7,279 | 10.03 | 73,001 |
2016-04-18 | Sohail Faysal A. (10% Owner) | Sale | 4,548 | 10.10 | 45,934 |
2016-04-15 | Sohail Faysal A. (10% Owner) | Sale | 18,210 | 10.22 | 186,142 |
2016-04-14 | Sohail Faysal A. (10% Owner) | Sale | 27,066 | 10.29 | 278,563 |
2016-04-13 | Sohail Faysal A. (10% Owner) | Sale | 12,692 | 10.16 | 128,976 |
2015-09-28 | Robitaille Gregory J | Option Ex | 410 | .32 | 131 |
2015-07-28 | Essex Capital Corp (10% Owner) | Buy | 30,000 | 15.00 | 450,000 |
2015-07-28 | Deerfield Private Design Fund Iii, L.p. | Buy | 400,000 | 15.00 | 6,000,000 |
2015-07-28 | Deerfield Private Design Fund Iii, L.p. | Sale | 166,666 | 15.00 | 2,499,990 |
2015-07-28 | Schuler Jack W (10% Owner) | Buy | 20,000 | 15.00 | 300,000 |
2015-07-27 | Heller Alan L (Director) | Option Ex | 30,540 | 1.31 | 40,160 |
Insider trading activities including stock purchases, stock sales, and option exercises of NEOS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Neos Therapeutics, Inc. (symbol NEOS, CIK number 1467652) see the Securities and Exchange Commission (SEC) website.